GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVGU) » Definitions » 10-Year Share Buyback Ratio

CSPC Pharmaceutical Group (FRA:CVGU) 10-Year Share Buyback Ratio : -0.80% (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is CSPC Pharmaceutical Group 10-Year Share Buyback Ratio?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

10-Year Share Buyback Ratio measures the average annual proportion of a company's outstanding shares repurchased over the past ten years. It is calculated as the annualized percentage change in shares outstanding from ten years ago to the current year. A positive ratio may indicate share buybacks over the period, while a zero or negative ratio may reflect no repurchases or potential share issuance. CSPC Pharmaceutical Group's current 10-Year Share Buyback Ratio was -0.80%.

FRA:CVGU's 10-Year Share Buyback Ratio is ranked better than
71.18% of 621 companies
in the Drug Manufacturers industry
Industry Median: -2.8 vs FRA:CVGU: -0.80

Competitive Comparison of CSPC Pharmaceutical Group's 10-Year Share Buyback Ratio

For the Drug Manufacturers - General subindustry, CSPC Pharmaceutical Group's 10-Year Share Buyback Ratio, along with its competitors' market caps and 10-Year Share Buyback Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CSPC Pharmaceutical Group's 10-Year Share Buyback Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CSPC Pharmaceutical Group's 10-Year Share Buyback Ratio distribution charts can be found below:

* The bar in red indicates where CSPC Pharmaceutical Group's 10-Year Share Buyback Ratio falls into.


;
;

CSPC Pharmaceutical Group 10-Year Share Buyback Ratio Calculation

This is the annualized percentage change in shares outstanding from ten years ago to the current year. The annualized percentage change is calculated with least-square regression based on the eleven years of annual data on Shares Outstanding (EOP).

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

CSPC Pharmaceutical Group (FRA:CVGU) 10-Year Share Buyback Ratio Explanation

A negative number means the company might be issuing new shares. A positive number indicates that the company is buying back shares.

Be Aware

Investors usually like share buybacks. But as pointed by Warren Buffett, only if a company buys back shares at the prices below the stock's intrinsic value, it rewards remaining shareholders. If a company buys its overvalued stocks back, it destroys shareholder value.

CSPC Pharmaceutical Group 10-Year Share Buyback Ratio Related Terms

Thank you for viewing the detailed overview of CSPC Pharmaceutical Group's 10-Year Share Buyback Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

CSPC Pharmaceutical Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CSPC Pharmaceutical Group Ltd (FRA:CVGU) » Definitions » 10-Year Share Buyback Ratio
Comparable Companies
HKSE:01666 HKSE:01643 LLY JNJ ABBV OCSE:NOVO B XSWX:ROG XSWX:NOVN LSE:AZN MRK AMGN PFE GILD XPAR:SAN BMY TSE:4519 LSE:GSK TSE:4568 SHSE:600276 XTER:BAYN
Traded in Other Exchanges
CSPCY:USA CHJTF:USA 01093:Hong Kong CVG:Germany
Address
No. 226 Huanghe Street, Hebei Province, Shijiazhuang, CHN, 050035
Website
https://www.cspc.com.hk
CSPC Pharmaceutical Group listed on the Hong Kong Stock Exchange in 1994 and is one of the largest pharmaceutical companies in China. Its biggest business segment is the finished drugs segment which accounts for nearly 80% of its total revenue. Now it has a diversified pipeline portfolio in seven therapeutic areas including nervous system diseases, oncology, anti-infective to cardiovascular disease, respiratory system disease, and metabolism. CSPC also has a bulk drug product segment including vitamin C and antibiotics.

CSPC Pharmaceutical Group Headlines

No Headlines